Алергијска болест (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Алергијска болест" in Serbian language version.

refsWebsite

Global rank Serbian rank

18nih.gov

4^th place

8^th place

18doi.org

2^nd place

4^th place

4archive.org

6^th place

5^th place

3semanticscholar.org

11^th place

23^rd place

1web.archive.org

1^st place

1csaci.ca

low place

1ultrazvuk-tarle.hr

low place

1lshtm.ac.uk

low place

archive.org

Shirai T, Matsui T, Suzuki K, Chida K. (2005). „Effect of pet removal on pet allergic asthma”. Chest. 127 (5): 1565—1571. PMID 15888829. doi:10.1378/chest.127.5.1565.
Sampson, HA; Muñoz-Furlong A; Campbell, RL; et al. (фебруар 2006). „Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium”. The Journal of Allergy and Clinical Immunology. 117 (2): 391—7. PMID 16461139. doi:10.1016/j.jaci.2005.12.1303.
Niebauer, K.; Dewilde, S.; Fox-Rushby, J.; Revicki, D. A. (2006). „Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma”. Ann Allergy Asthma Immunol. 96 (2): 316—326. PMID 16498854. doi:10.1016/S1081-1206(10)61242-2. .
Flood-Page, P.; Menzies-Gow, A.; Phipps, S.; Ying, S.; Wangoo, A.; Ludwig, M. S.; Barnes, N.; Robinson, D.; Kay, A. B. (2003). „Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics”. J Clin Invest. 112 (7): 1029—1036. PMC 198522 . PMID 14523040. doi:10.1172/JCI17974.

csaci.ca

Simons, FE; World Allergy Organization (мај 2010). „World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settings” (PDF). Annals of Allergy, Asthma & Immunology. 104 (5): 405—12. PMID 20486330. doi:10.1016/j.anai.2010.01.023. Архивирано из оригинала (PDF) 26. 04. 2012. г. Приступљено 02. 05. 2017.

doi.org

Finn, DF; Walsh, JJ (септембар 2013). „Twenty-first century mast cell stabilizers.”. British Journal of Pharmacology. 170 (1): 23—37. PMC 3764846 . PMID 23441583. doi:10.1111/bph.12138.
May, JR; Dolen, WK (децембар 2017). „Management of Allergic Rhinitis: A Review for the Community Pharmacist.”. Clinical Therapeutics. 39 (12): 2410—19. PMID 29079387. doi:10.1016/j.clinthera.2017.10.006 .
Johansson SGO, Hourihane JOB, Bousquet J, Bruijnzeel-Koomen C,Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, Cauwenberge van P,Hage-Hamsten van M, Wutrich B. „Nomenclature for allergy, An EAACIposition statement from the EAACI nomenclature task force”. Allergy. 56: 813—24. 2001. PMID 11551246. doi:10.1034/j.1398-9995.2001.t01-1-00001.x. .
Johansson SGO, Hourihane JOB, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, Cauwenberge van P, Hage-Hamsten van M, Wutrich B. (2001). „Nomenclature for allergy, An EAACI position statement from the EAACI nomenclature task force.”. Allergy. 56 (9): 813—24. PMID 11551246. doi:10.1034/j.1398-9995.2001.t01-1-00001.x. .
Shirai T, Matsui T, Suzuki K, Chida K. (2005). „Effect of pet removal on pet allergic asthma”. Chest. 127 (5): 1565—1571. PMID 15888829. doi:10.1378/chest.127.5.1565.
Martinez, FD (2007). „Genes, environments, development and asthma: a reappraisal”. Eur Respir J. 29 (1): 179—84. PMID 17197483. S2CID 12061972. doi:10.1183/09031936.00087906.
Lemanske RF, Busse WW (2010). „Asthma: clinical expression and molecular mechanisms”. J. Allergy Clin. Immunol. 125 (2 Suppl 2): S95—102. PMC 2853245 . PMID 20176271. doi:10.1016/j.jaci.2009.10.047.
Spergel JM. (2005). „Atopic march: link to upper airways.”. Curr Opin Allergy Clin Immunol. 5 (1): 17—21. PMID 15643339. S2CID 45756239. doi:10.1097/00130832-200502000-00005. .
Poley GE, Slater JE. (2000). „Latex allergy”. J Allergy Clin Imunol. 105 (6 Pt 1): 1054—62. PMID 10856135. doi:10.1067/mai.2000.106925. .
Simons, FE; World Allergy Organization (мај 2010). „World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settings” (PDF). Annals of Allergy, Asthma & Immunology. 104 (5): 405—12. PMID 20486330. doi:10.1016/j.anai.2010.01.023. Архивирано из оригинала (PDF) 26. 04. 2012. г. Приступљено 02. 05. 2017.
Sampson, HA; Muñoz-Furlong A; Campbell, RL; et al. (фебруар 2006). „Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium”. The Journal of Allergy and Clinical Immunology. 117 (2): 391—7. PMID 16461139. doi:10.1016/j.jaci.2005.12.1303.
Alexander, C.; Tarzi, M.; Larché, M.; Kay, A. B. (2005). „The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects”. Allergy. 60 (10): 1269—1274. PMID 16134993. S2CID 22275691. doi:10.1111/j.1398-9995.2005.00885.x.
Niebauer, K.; Dewilde, S.; Fox-Rushby, J.; Revicki, D. A. (2006). „Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma”. Ann Allergy Asthma Immunol. 96 (2): 316—326. PMID 16498854. doi:10.1016/S1081-1206(10)61242-2. .
Leung, Donald Y.M.; Sampson, Hugh A.; Yunginger, John W.; Burks, A. Wesley; Schneider, Lynda C.; Wortel, Cornelis H.; Davis, Frances M.; Hyun, John D.; Shanahan, William R. (2003). „Effect of Anti-IgE Therapy in Patients with Peanut Allergy”. New England Journal of Medicine. 348 (11): 986—993. PMID 12637608. doi:10.1056/NEJMoa022613. .
Flood-Page, P.; Menzies-Gow, A.; Phipps, S.; Ying, S.; Wangoo, A.; Ludwig, M. S.; Barnes, N.; Robinson, D.; Kay, A. B. (2003). „Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics”. J Clin Invest. 112 (7): 1029—1036. PMC 198522 . PMID 14523040. doi:10.1172/JCI17974.
Berry, M. A.; Hargadon, B.; Shelley, M.; Parker, D.; Shaw, D. E.; Green, R. H.; Bradding, P.; Brightling, C. E.; Wardlaw, A. J.; Pavord, I. D. (2006). „Evidence of a role of tumor necrosis factor alpha in refractory asthma”. New England Journal of Medicine. 354 (7): 697—708. PMID 16481637. doi:10.1056/NEJMoa050580.
Terreehorst I, Hak E, Oosting AJ; et al. (2003). „Evaluation of impermeable covers for bedding in patients with allergic rhinitis”. New England Journal of Medicine. 349 (3): 237—246. PMID 12867607. doi:10.1056/NEJMoa023171.
Woodcock A, Forster L, Matthews E; et al. (2003). „Medical Research Council General Practice Research Framework. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma.” (PDF). New England Journal of Medicine. 349 (3): 225—236. PMID 12867606. doi:10.1056/NEJMoa023175.

lshtm.ac.uk

researchonline.lshtm.ac.uk

Woodcock A, Forster L, Matthews E; et al. (2003). „Medical Research Council General Practice Research Framework. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma.” (PDF). New England Journal of Medicine. 349 (3): 225—236. PMID 12867606. doi:10.1056/NEJMoa023175.

nih.gov

ncbi.nlm.nih.gov

Finn, DF; Walsh, JJ (септембар 2013). „Twenty-first century mast cell stabilizers.”. British Journal of Pharmacology. 170 (1): 23—37. PMC 3764846 . PMID 23441583. doi:10.1111/bph.12138.
May, JR; Dolen, WK (децембар 2017). „Management of Allergic Rhinitis: A Review for the Community Pharmacist.”. Clinical Therapeutics. 39 (12): 2410—19. PMID 29079387. doi:10.1016/j.clinthera.2017.10.006 .
Johansson SGO, Hourihane JOB, Bousquet J, Bruijnzeel-Koomen C,Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, Cauwenberge van P,Hage-Hamsten van M, Wutrich B. „Nomenclature for allergy, An EAACIposition statement from the EAACI nomenclature task force”. Allergy. 56: 813—24. 2001. PMID 11551246. doi:10.1034/j.1398-9995.2001.t01-1-00001.x. .
Johansson SGO, Hourihane JOB, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, Cauwenberge van P, Hage-Hamsten van M, Wutrich B. (2001). „Nomenclature for allergy, An EAACI position statement from the EAACI nomenclature task force.”. Allergy. 56 (9): 813—24. PMID 11551246. doi:10.1034/j.1398-9995.2001.t01-1-00001.x. .
Shirai T, Matsui T, Suzuki K, Chida K. (2005). „Effect of pet removal on pet allergic asthma”. Chest. 127 (5): 1565—1571. PMID 15888829. doi:10.1378/chest.127.5.1565.
Martinez, FD (2007). „Genes, environments, development and asthma: a reappraisal”. Eur Respir J. 29 (1): 179—84. PMID 17197483. S2CID 12061972. doi:10.1183/09031936.00087906.
Lemanske RF, Busse WW (2010). „Asthma: clinical expression and molecular mechanisms”. J. Allergy Clin. Immunol. 125 (2 Suppl 2): S95—102. PMC 2853245 . PMID 20176271. doi:10.1016/j.jaci.2009.10.047.
Spergel JM. (2005). „Atopic march: link to upper airways.”. Curr Opin Allergy Clin Immunol. 5 (1): 17—21. PMID 15643339. S2CID 45756239. doi:10.1097/00130832-200502000-00005. .
Poley GE, Slater JE. (2000). „Latex allergy”. J Allergy Clin Imunol. 105 (6 Pt 1): 1054—62. PMID 10856135. doi:10.1067/mai.2000.106925. .
Simons, FE; World Allergy Organization (мај 2010). „World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settings” (PDF). Annals of Allergy, Asthma & Immunology. 104 (5): 405—12. PMID 20486330. doi:10.1016/j.anai.2010.01.023. Архивирано из оригинала (PDF) 26. 04. 2012. г. Приступљено 02. 05. 2017.
Sampson, HA; Muñoz-Furlong A; Campbell, RL; et al. (фебруар 2006). „Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium”. The Journal of Allergy and Clinical Immunology. 117 (2): 391—7. PMID 16461139. doi:10.1016/j.jaci.2005.12.1303.
Alexander, C.; Tarzi, M.; Larché, M.; Kay, A. B. (2005). „The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects”. Allergy. 60 (10): 1269—1274. PMID 16134993. S2CID 22275691. doi:10.1111/j.1398-9995.2005.00885.x.
Niebauer, K.; Dewilde, S.; Fox-Rushby, J.; Revicki, D. A. (2006). „Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma”. Ann Allergy Asthma Immunol. 96 (2): 316—326. PMID 16498854. doi:10.1016/S1081-1206(10)61242-2. .
Leung, Donald Y.M.; Sampson, Hugh A.; Yunginger, John W.; Burks, A. Wesley; Schneider, Lynda C.; Wortel, Cornelis H.; Davis, Frances M.; Hyun, John D.; Shanahan, William R. (2003). „Effect of Anti-IgE Therapy in Patients with Peanut Allergy”. New England Journal of Medicine. 348 (11): 986—993. PMID 12637608. doi:10.1056/NEJMoa022613. .
Flood-Page, P.; Menzies-Gow, A.; Phipps, S.; Ying, S.; Wangoo, A.; Ludwig, M. S.; Barnes, N.; Robinson, D.; Kay, A. B. (2003). „Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics”. J Clin Invest. 112 (7): 1029—1036. PMC 198522 . PMID 14523040. doi:10.1172/JCI17974.
Berry, M. A.; Hargadon, B.; Shelley, M.; Parker, D.; Shaw, D. E.; Green, R. H.; Bradding, P.; Brightling, C. E.; Wardlaw, A. J.; Pavord, I. D. (2006). „Evidence of a role of tumor necrosis factor alpha in refractory asthma”. New England Journal of Medicine. 354 (7): 697—708. PMID 16481637. doi:10.1056/NEJMoa050580.
Terreehorst I, Hak E, Oosting AJ; et al. (2003). „Evaluation of impermeable covers for bedding in patients with allergic rhinitis”. New England Journal of Medicine. 349 (3): 237—246. PMID 12867607. doi:10.1056/NEJMoa023171.
Woodcock A, Forster L, Matthews E; et al. (2003). „Medical Research Council General Practice Research Framework. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma.” (PDF). New England Journal of Medicine. 349 (3): 225—236. PMID 12867606. doi:10.1056/NEJMoa023175.

semanticscholar.org

api.semanticscholar.org

Martinez, FD (2007). „Genes, environments, development and asthma: a reappraisal”. Eur Respir J. 29 (1): 179—84. PMID 17197483. S2CID 12061972. doi:10.1183/09031936.00087906.
Spergel JM. (2005). „Atopic march: link to upper airways.”. Curr Opin Allergy Clin Immunol. 5 (1): 17—21. PMID 15643339. S2CID 45756239. doi:10.1097/00130832-200502000-00005. .
Alexander, C.; Tarzi, M.; Larché, M.; Kay, A. B. (2005). „The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects”. Allergy. 60 (10): 1269—1274. PMID 16134993. S2CID 22275691. doi:10.1111/j.1398-9995.2005.00885.x.

ultrazvuk-tarle.hr

Tarle-Bajić, Nives. „Alergološko testiranje (određivanje specifičnih IgE antitijela) iz krvi”. ultrazvuk-tarle.hr. Приступљено 9. 5. 2017.

web.archive.org

Simons, FE; World Allergy Organization (мај 2010). „World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settings” (PDF). Annals of Allergy, Asthma & Immunology. 104 (5): 405—12. PMID 20486330. doi:10.1016/j.anai.2010.01.023. Архивирано из оригинала (PDF) 26. 04. 2012. г. Приступљено 02. 05. 2017.